This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Oct;24(10):e402.

doi: 10.1016/S1470-2045(23)00413-8.

Common Sense Oncology: including everyone

Nicolas André¹

Affiliations

Affiliation

¹ Service d'Hématologie et Oncologie Pédiatrique, Timone Hospital, AP-HM, Marseille, France; Reverse Molecular Pharmacology in Pediatric Oncology, Centre de Recherche en Cancérologie de Marseille, Aix-Marseille Université, CNRS, INSERM, Marseille, France; Metronomics Global Health Initiative, Marseille, France. Electronic address: nicolas.andre@ap-hm.fr.

PMID: 37797640
DOI: 10.1016/S1470-2045(23)00413-8

Comment

Common Sense Oncology: including everyone

Nicolas André. Lancet Oncol. 2023 Oct.

. 2023 Oct;24(10):e402.

doi: 10.1016/S1470-2045(23)00413-8.

Author

Nicolas André¹

Affiliation

¹ Service d'Hématologie et Oncologie Pédiatrique, Timone Hospital, AP-HM, Marseille, France; Reverse Molecular Pharmacology in Pediatric Oncology, Centre de Recherche en Cancérologie de Marseille, Aix-Marseille Université, CNRS, INSERM, Marseille, France; Metronomics Global Health Initiative, Marseille, France. Electronic address: nicolas.andre@ap-hm.fr.

PMID: 37797640
DOI: 10.1016/S1470-2045(23)00413-8

No abstract available

PubMed Disclaimer

Conflict of interest statement

I declare no competing interests.

Comment in

Common Sense Oncology: including everyone - Authors' reply.
Booth CM, Sengar M, Goodman A, Wilson B, Gyawali B. Booth CM, et al. Lancet Oncol. 2023 Oct;24(10):e404. doi: 10.1016/S1470-2045(23)00464-3. Lancet Oncol. 2023. PMID: 37797642 No abstract available.

Comment on

Common Sense Oncology: including everyone.
Ergun Y. Ergun Y. Lancet Oncol. 2023 Oct;24(10):e403. doi: 10.1016/S1470-2045(23)00359-5. Lancet Oncol. 2023. PMID: 37797641 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science